Business
Meatiply secures seed funding for expansion and commercialisation of cell-based meat

Phoebe Fraser
11 December 2023
11 December 2023
Meatiply secures seed funding for expansion and commercialisation of cell-based meat

Singapore-based cell-based meat company Meatiply has secured $3.75 million in the first close of its seed funding round.
The funding will help Meatiply expand its R&D capabilities and scale-up production of its cell-based meat, for more extensive product co-development with commercial partners. A new facility is expected in 2024, two years ahead of its targeted commercial launch in 2026.
Meatiply’s co-founder and CEO Elwin Tan said: “Despite a more cautious investment approach this year, investors were excited by our development strategy. Likewise, we are thrilled that our investors share our vision to leverage Meatiply’s strong upstream capabilities to create complex and functional products that not only justifies the use of animal cells, but also results in significant cost reductions.”
The round was co-led by existing investor Wavemaker Partners and AgFunder, with participation from Seeds Capital, the venture investment arm of Enterprise Singapore.
Paul Santos, managing partner at Wavemaker Partners, commented: “As deep tech investors, we believe that cultivated meat companies offer more robust and defensible business models compared to other alternative meat technologies. While the challenge of meeting product launch deadlines persists for many companies, the Meatiply team has demonstrated the ability to achieve meaningful results within shorter timeframes and with considerably less funding. Their achievements in developing hybrid structured poultry prototypes have particularly impressed us.”
Jason Chua, co-founder and chief scientific officer at Meatiply, added: “Meatiply believes in maximising the potential of each cell type. Our focus on the production of complex value-added compounds using cells will allow us to create cultivated meat products with added health benefits. This strategic entry point will give consumers more reasons to embrace cultivated technologies. Besides meat, we are also positioned for opportunities to commercialise in the nutraceutical and wellness market.”
A second close is scheduled to take place in Q1 2024.
#Meatiply #Singapore
Related news
Singapore awards $32.3m to boost alternative protein and food safety research
The Singapore Food Agency (SFA) has awarded $32.3 million in research funding to 11 projects under the second phase of the Singapore Food Story R&D Programme, aimed at advancing innovation in future foods and food safety.
Hoxton Farms submits regulatory dossier for cultivated fat in Singapore
Hoxton Farms has submitted a regulatory dossier to the Singapore Food Agency (SFA) seeking market approval for its cultivated fat ingredient, Hoxton Fat.
Ajinomoto debuts Solein-based dairy-free coffee in Singapore
Japanese food manufacturer Ajinomoto has expanded its Solein-powered product line with the launch of a new ready-to-drink coffee under its sustainable brand Atlr.72.
Business
Meatiply secures seed funding for expansion and commercialisation of cell-based meat

Phoebe Fraser
11 December 2023









